MedStar Health Advances in the Management of Prostate, Bladder and Kidney Cancers 2021

MedStar Health Advances in the Management of Prostate, Bladder and Kidney Cancers 2021

$10.00

+ Include: 33 videos + 1 pdf, size: 4.02 GB

+ Target Audience: oncology, pathology, radiation oncology, surgery, urology

Description

+ Include: 33 videos + 1 pdf, size: 4.02 GB

+ Target Audience: oncology, pathology, radiation oncology, surgery, urology

+ Sample video: contact me for sample video

+ Topics:

Agenda.pdf

Keynote Progress in Prostate Cancer Management in 2020.mp4

Keynote Questions and Discussion.mp4

Session I Management of Early-Stage Prostate Cancer – Emerging Role of Focal Therapy for Localized Prostate Cancer.mp4

Session I Management of Early-Stage Prostate Cancer – Frontiers in Imaging in the Pretreatment Setting.mp4

Session I Management of Early-Stage Prostate Cancer – Intro + Retzius-Sparing Robot Assisted Radical Prostatectomy Evolution and Outcomes.mp4

Session I Management of Early-Stage Prostate Cancer – Prostate Cancer Health Disparities.mp4

Session I Management of Early-Stage Prostate Cancer – Questions and Discussion.mp4

Session II Management of High-Risk and Advanced Prostate Cancer – Intro + Personalized Approach to Postoperative Radiation and Hormonal Therapy in Men with Biochemical Recurrence Following Prostatectomy.mp4

Session II Management of High-Risk and Advanced Prostate Cancer – Personalized Approach to Postoperative Radiation and Hormonal Therapy in Men with Biochemical Recurrence Following Prostatectomy.mp4

Session II Management of High-Risk and Advanced Prostate Cancer – Questions and Discussion.mp4

Session II Management of High-Risk and Advanced Prostate Cancer – Radiation for Biochemically-Recurrent and Oligometastatic Prostate Cancer.mp4

Session III Management of Metastatic Castration Resistant Prostate Cancer – Intro + Therapeutic Potential of PARP Inhibition in Prostate Cancer.mp4

Session III Management of Metastatic Castration Resistant Prostate Cancer – New Biology, Novel Approaches and Targeted Therapies for Prostate Cancer.mp4

Session III Management of Metastatic Castration Resistant Prostate Cancer – New Immunotherapeutic Approaches to Advanced Prostate Cancer.mp4

Session III Management of Metastatic Castration Resistant Prostate Cancer – PSMA-Targeted Radionuclide Therapy for Advanced Prostate Cancer.mp4

Session III Management of Metastatic Castration Resistant Prostate Cancer – Questions and Discussion + Closing Remarks Day 1.mp4

Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Intro.mp4

Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Keynote Lecture Targeting the HIF-2-VEGF Axis in RCC.mp4

Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Novel Endpoints and Predictive Biomarkers for RCC.mp4

Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Questions and Discussion.mp4

Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Update on Systemic Therapy for Metastatic ccRCC.mp4

Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Update on the Surgical Management of RCC and the Impact of COVID-19 Pandemic.mp4

Session IV Recent Advances in High Risk and Metastatic Kidney Cancer Treatment – Update on the Treatment of nccRCC.mp4

Session V Bladder Cancer – Evolving Role of Immunotherapy and Targeted Therapies in the Systemic Management of Urothelial Carcinoma.mp4

Session V Bladder Cancer – Intro.mp4

Session V Bladder Cancer – Novel Approaches to Improve Outcomes in Non-Muscle Invasive Urothelial Carcinoma of the Bladder.mp4

Session V Bladder Cancer – Organ Sparing Cystectomy.mp4

Session V Bladder Cancer – Questions and Discussion + Closing Remarks Day 2.mp4

Session V Bladder Cancer – Radio-sensitization Strategies and Bladder Preservation.mp4

Session V Bladder Cancer – Updates in Systemic Therapy for Bladder Cancers.mp4

Session V Bladder Cancer – Upper Tract Urothelial Carcinoma; Unique Genetics, Biology and Evolving Therapeutics.mp4

Welcome Remarks Day 1.mp4

Welcome Remarks Day 2.mp4

Reviews

There are no reviews yet.

Be the first to review “MedStar Health Advances in the Management of Prostate, Bladder and Kidney Cancers 2021”

Your email address will not be published. Required fields are marked *

Related Products